RAPIBLOC subst sèche 300 mg flac
7680686110014
CH-68611
C07AB14
02.03.0.
1 / 3
google
Details
- Product number
- 6861101
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- landiololi hydrochloridum 300 mg corresp. landiololum 280 mg, mannitolum, natrii hydroxidum corresp. natrium max. 4.6 mg, pro vitro.
Articles (1)
Rapibloc 300 mg, Pulver zur Herstellung einer Infusionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | WIZUS |
|
(N/A)
|
280.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Authorization holder
OrPha Swiss GmbH
8700 Küsnacht ZH
Authorization information
- Swissmedic authorization number
- 68611
- Drug name
- Rapibloc, Pulver zur Herstellung einer Infusionslösung
- Galenic form
- PULVI
- ATC Code
- C07AB14
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/10/2022
- Authorization expiration date
- 18/10/2027
- IT number
- 02.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RAPIBLOC subst sèche 300 mg flac
- Description (DE)
- RAPIBLOC Trockensub 300 mg Durchstf
- Market launch
- 19/10/2022
- Narcotic (BTM)
- No